Načítá se...

Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours

Background—Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both changed the management of gastroenteropancreatic endocrine tumours, but very few data are available on the use of SRS and octreotide to visualise and treat somatostatinomas. 
Method—The results of SRS and octreotide...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Angeletti, S, Corleto, V, Schillaci, O, Marignani, M, Annibale, B, Moretti, A, Silecchia, G, Scopinaro, F, Basso, N, Bordi, C, Delle, F
Médium: Artigo
Jazyk:Inglês
Vydáno: 1998
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727128/
https://ncbi.nlm.nih.gov/pubmed/9691916
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!